Dovitinib in Neuroendocrine Tumors
by on Tuesday, July 10th, 2012 | No Comments
Conditions: Advanced Metastatic Paraganglioma; Advanced Metastatic Pheochromocytoma; Recurrent Paraganglioma; Recurrent Pheochromocytoma; Unresectable Paraganglioma; Unresectable Pheochromocytoma
Intervention: Drug: Dovitinib
Sponsors: Abramson Cancer Center of the University of Pennsylvania; Abramson Cancer Center of the University of Pennsylvania
Active, not recruiting – verified July 2012
Follow this link: Dovitinib in Neuroendocrine Tumors